Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.43 USD | -0.22% | -2.54% | -5.89% |
Feb. 28 | Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The firm trades with high earnings multiples: 23.16 times its 2024 earnings per share.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.89% | 3.11B | C+ | ||
+0.71% | 53.67B | A- | ||
-14.45% | 17.17B | A- | ||
-9.04% | 12.78B | A | ||
-2.22% | 7.35B | B | ||
-19.97% | 5.26B | B- | ||
+6.08% | 3.2B | C- | ||
-8.88% | 2.93B | B+ | ||
+1.63% | 3.02B | C | ||
+8.22% | 2.62B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBRA Stock
- Ratings Sabra Health Care REIT, Inc.